Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Opty / Re: Notes from the PTSC SHM meeting in Chicago

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Opty / Re: Notes from the PTSC SHM meeting in Chicago - 1/28/2010

in response to

Opty / Re: Notes from the PTSC SHM meeting in Chicago - 1/28/2010

lambertslunatics

posted on Jan 29, 2010 03:54PM

<The umbrella strategy was/is not a flawed strategy,>

I'm reading this as you want an entirely new BOD seated to start all over with adding layers of managment in order to continue M&A under the umbrella strategy?

If so, we agree to disagree.

I do not think the strategy could have worked, no matter who was CEO or who was on the BOD. And I don't think a new BOD or new managemet can make it work until we are at least assured of significant continuing revenue from the MMP. And for that to happen, IMO, we need most of the MMP to be recertified by the PTO w/o loss of strength, and probably some siginifcant wins on the litigation front.

IMO, we attempted the umbrella strategy too soon from a financial point of view. I am not saying that the BOD deserves their jobs or the renumeration they get. Hell no. I just can't see making the same mistake twice, if that is indeed what you are proposing.